27/09/22 -"2 positive news: 1) divestment of L.A. Schmitt might lead to EUR ~2mn _cash inflow, 2) new CFO as “old” CFO becomes CEO of new CRISPR entity"
27/09/22 -"2 positive news: 1) divestment of L.A. Schmitt might lead to EUR ~2mn _cash inflow, 2) new CFO as “old” CFO becomes CEO of new CRISPR entity"
AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.
| Corporate broking | NO |
| Trading in corporate shares | NO |
| Analyst ownership | NO |
| Advising of corporate (strategy, marketing, debt, etc) | NO |
| Research paid for by corporate | NO |
| Provision of corporate access paid for by corporate | NO |
| Link between and a banking entity | NO |
| Brokerage activity at AlphaValue | NO |